Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: GlobeNewswire
BEDFORD, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) announced today with great sadness that Joseph Darling, its President and Chief Executive Officer, passed away unexpectedly on January 29, 2020 in Upstate New York. He was 62. President and CEO “We are shocked and greatly saddened by the passing of Joe Darling,” said Joseph Bower, Chairman of Anika's Board of Directors. “He was a visionary leader with a passion for healthcare, a devoted father to his children and a good friend. On behalf of the Board of Directors and all Anika employees, as well as the many people he worked with and mentored over the years, we would like to extend our deepest condolences to the Darling family, including his wife, Maureen, and children, Jon and Jordan. We will miss Joe de
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.MarketBeat
- Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Arthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsPR Newswire
- Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
ANIK
Earnings
- 10/31/24 - Miss
ANIK
Sec Filings
- 11/4/24 - Form 10-Q
- 10/31/24 - Form 8-K
- 10/31/24 - Form 8-K
- ANIK's page on the SEC website